How to Evaluate and Shortlist a Contract Pharmaceutical Manufacturer

If you only do one thing carefully in a private-label launch, make it manufacturer selection. The manufacturer you choose determines your product quality, your delivery reliability, and ultimately whether your customers trust your brand. Here's a practical framework for evaluating one.

Start with licensing and certification — but understand what they mean

Drug manufacturing licence. Any legitimate pharmaceutical manufacturer in India must hold a valid manufacturing licence appropriate to the product categories they produce, issued by the relevant state or central drug authority. Ask to see it, and verify it independently rather than taking a screenshot at face value.

WHO-GMP (Good Manufacturing Practice). This is a recognized international standard for pharmaceutical manufacturing quality systems — covering things like facility hygiene, equipment qualification, documentation practices, and batch traceability. A WHO-GMP certification is a meaningful signal that a facility has been independently assessed against this standard, but it's not a guarantee of perfection on every batch — treat it as one strong data point, not the whole picture.

ISO 9001. This is a general quality-management-system certification (not pharma-specific) indicating the organization has documented, auditable processes. Useful as a secondary signal alongside WHO-GMP, not a replacement for it.

Neither certification tells you about responsiveness, communication quality, or whether the manufacturer is a good fit for your product specifically — which is why the next sections matter just as much.

Questions worth asking directly

• What's your experience with this specific dosage form and category? A manufacturer might be excellent at tablets and have very limited experience with, say, sterile injectables. Ask for examples.
• What's your minimum order quantity (MOQ) for this product, and does it flex? MOQs vary widely by dosage form and by manufacturer. Make sure the MOQ matches what you can realistically sell.
• What's your typical lead time, and what causes delays? Get a realistic number, not an optimistic one. Ask what happened the last time they missed a deadline.
• Where does your API (active pharmaceutical ingredient) come from? Reputable manufacturers can tell you their API sourcing and should be willing to share relevant documentation.
• What does your quality control process look like for a batch? You're listening for specifics — batch testing, documentation, retention samples — not a vague "we test everything."
• Can I see packaging samples or photos from past production? This tells you a lot about finish quality before you commit.
• What happens if a batch fails internal QC? Their answer tells you whether they have a real process or are making it up as they go.

Red flags

• Reluctance to share licence or certification documents, or documents that don't match what's stated.
• Prices significantly below the rest of the market with no clear explanation (could indicate corners being cut on inputs or process).
• Vague or evasive answers about API sourcing.
• No clear minimum order quantity or pricing structure — pricing should be reasonably transparent, even if it's tiered by volume.
• Pressure to commit or pay before you've seen documentation or samples.
• Unwillingness to put terms (lead time, payment terms, MOQ) in writing.

Beyond the checklist

Certifications and documents establish a baseline of legitimacy, but the working relationship matters just as much — how responsive they are, how clearly they communicate problems, and whether they treat your first (likely small) order with the same care as a large one. A short trial order, where feasible, can tell you more than any document.

A note on this content

This is general informational guidance, not a substitute for your own due diligence or for legal/regulatory advice. Verification standards and required certifications can vary by product category — confirm specifics relevant to your situation with a qualified consultant or the appropriate drug authority.